Skip to content

Verification on the effects of beverage intake on vascular endothelial function and postprandial energy metabolism in healthy subjects.

Verification on the effects of beverage intake on vascular endothelial function and postprandial energy metabolism in healthy subjects. - Verification on the effects of beverage intake on vascular endothelial function and postprandial energy metabolism in healthy subjects.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053308
Enrollment
30
Registered
2024-01-23
Start date
2024-01-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Intake of active food for 4 weeks - Washout period (4 weeks) - Intake of placebo food for 4 weeks Intake of placebo food for 4 weeks - Washout period (4 weeks) - Intake of active food for 4 weeks

Sponsors

M&I Science CORP.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Male and female subjects between 40 and 65 years of age at the time consent is obtained. 2) Subjects who are healthy and free from chronic diseases. 3) Subjects who are with a BMI of at least 22 and less than 30 kg/m2 and who are not obese. 4) Subjects who exercise less than once a week. 5) Subjects who have received a thorough explanation of their participation in this study, and who have given their free and voluntary written consent based on a thorough understanding of the study.

Exclusion criteria

Exclusion criteria: 1) Subjects who have any disease and are being treated with medication. 2) Subjects who are obese (BMI of 25 kg/m2 or more and any of the following 1 through 12). 1.Abdominal circumference Male 85 cm or more, Female 90 cm or more 2.Have been diagnosed with impaired glucose tolerance (type 2 diabetes, impaired glucose tolerance) 3.Have been diagnosed with dyslipidemia 4.Have been diagnosed with hypertension 5.Have been diagnosed with hyperuricemia or gout 6.Have been diagnosed with coronary artery disease, myocardial infarction, or angina pectoris 7.Has been diagnosed with cerebral infarction, cerebral thrombosis, or transient ischemic attack (TIA) 8.Fatty liver (ever diagnosed with non-alcoholic fatty liver disease (NAFLD)) 9.Menstrual abnormalities, infertility 10.Have been diagnosed with sleep apnea syndrome (SAS), obesity hypoventilation syndrome 11.Have been diagnosed with musculoskeletal disease, osteoarthritis (knee, hip), osteoarthritis of the spine, osteoarthritis of the fingers 12.Have been diagnosed with obesity-related kidney disease 3) Subjects who suffering from serious or allergic diseases. 4) Subjects who regularly use dietary supplements or other health foods during the study period. 5) Subjects who consume excessive amounts of purple (anthocyanin-containing) foods. 6) Heavy drinkers of alcohol. 7) Smokers. 8) Subjects who live day and night in reverse (night shift, etc.). 9) Subjects who exercise more than twice a week. 10) Subjects who plan to make significant changes in their exercise habits or lifestyle, such as work or study, during the study period.

Design outcomes

Primary

MeasureTime frame
Fat Oxidation

Secondary

MeasureTime frame
Energy expenditure, carbohydrate oxidation, respiratory quotient, FMD, body weight, body fat, and bodily sensation value

Countries

Japan

Contacts

Public ContactMasao Matsuoka

M&I Science CORP. Clinical Development Department

m.matsuoka@mis21.co.jp06-7878-6780

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026